. 2003 Oct;41(10):4793–4795. doi: 10.1128/JCM.41.10.4793-4795.2003

TABLE 2.

Likelihood ratios of different log₁₀ HBV DNA levels to predict HBeAg reversion

Group (time)^a	Log₁₀ HBV DNA	No. (%) of patients in subgroup:		Likelihood ratio
Group (time)^a	Log₁₀ HBV DNA	A	B	Likelihood ratio
I (C)	<4	11 (55.0)	2 (15.4)	0.3
	4-5	8 (40.0)	5 (38.5)	1.0
	>5	1 (5.0)	6 (46.2)	9.2
II (N1)	<4	19 (65.5)	2 (18.2)	0.3
	4-5	7 (24.1)	2 (18.2)	0.8
	>5	3 (10.3)	7 (53.8)	5.2

Group IA, sustained HBeAg seroconversion; group IB, HBeAg reversion after seroconversion; group IIA, persistently HBeAg-negative inactive disease; group IIB, HBeAg reversion in HBeAg-negative patients; time C, first disappearance of HBeAg in HBeAg-positive patients; time N1, initial visit of HBeAg-negative patients.